Additional Positive Trial Results Reported for Dysport in Cerebral Palsy with Lower Limb Spasticity
News
Ipsen Biopharmaceuticals reported additional results from an extended clinical trial evaluating the safety and effectiveness of Dysport (botulinum toxin type A) in children with lower limb spasticity due to cerebral palsy at ... Read more